Mangaluru's first theme-based mall 'Transit One' set for launch

Kasaragod, Apr 6: Even as the number of positive cases of Novel Coronovirus is on increase in this district, the ten-member medical team from Thiruvananthapuram on Monday will inspect and review modalities to convert the proposed Kasaragod medical college into a COVID-19 hospital.

Given the constraints being faced by the district hospital in Kanhangad near here, the 200-beded Kasaragod medical college hospital in Ukkinada near here would be equipped to cater to the Covid-19 patients on isolation.

The ten member medical experts who reached here late on Sunday, are on a special mission to immediately equip the hospital as to convert it as a Covid-19 centre.

Bengaluru, Apr 28: Ayurveda company, TotalAyurvedaCare.com recently launched a novel telemedicine platform that blends traditional Ayurvedic practices with modern technology, giving patients face-to-face interactions with Ayurvedic doctors.

Through the website, patients can book an appointment with a doctor and receive a consultation. Following this consultation, the doctor will prescribe Ayurvedic medicines and provide nutritional advice.

"COVID-19 has brought many unexpected changes to our lives, especially in the healthcare sectors where patients are now asked not to visit hospitals or doctors clinics unless it is a dire emergency. While social distancing and hand washing are some of the keys to containing the spread of the virus, we realized that boosting one's immunity plays a very vital role in keeping healthy. Our Telemedicine portal is ideal as patients can have access to Ayurvedic doctors at the comfort of their homes while minimizing risk to both patient and doctor", said Ed Lateef, Founder and CEO of TotalAyurvedaCare.com.

"The holistic care and treatment is completely personalized for every individual. With highly qualified and experienced doctors, we are on a mission to make the global community a healthy and happy place with Ayurveda. The online platform of TotalAyurvedaCare.com is for everyone to transform their lives. Ayurveda is the science of life and longevity and teaches us about the power of nature, its cycles, and its elements. We understand that Ayurveda is aimed at not only treating the condition but also helps to maintain the balance of soul and mind", he added.

TotalAyurvedaCare's objective is to increase accessibility of Ayurvedic treatments, with the streamlined website allowing patients to register for online consultation easily.

During the registration process, the patient will have to select their condition, doctor of choice and schedule the appointment. Payments occur online through a secured payment gateway.

Currently, the platform supports payment methods including netbanking, debit card, credit card, and PayTM. The platform also allows patients to review their doctors.

TotalAyurvedaCare.com is a division of Total Herbal Care, a company with strategic interests in herbal brands. Founded by Ed Lateef in 2001, for the retail and distribution of Ayurvedic products in the US, it also began operations in Europe in 2003 and then was merged with The Himalaya Drug Company LTD Europe (SIA The Himalaya Drug Company), which was co-founded by Ed Lateef.

As a part of their launch, TotalAyurvedaCare.com is offering free appointments of 30 minutes each for the first 200 participants. The online Ayurvedic Doctor consultation from Total Ayurveda Care is suitable for all the age groups including children.

The highly qualified and experienced Ayurvedic physicians offer personalized consultation for multiple health issues like diabetes, obesity, skin conditions, hair issues, hypertension, stress, anxiety, gastrointestinal problems, etc.

Total Ayurveda Care also offers specialized nutritional consulting, which is based on your current state of health, dietary habits and health issues.

New Delhi, Jun 13: Loss of smell or taste has been added to the list of COVID-19 symptoms, according to the revised clinical management protocols released by the Union Health Ministry on Saturday.

The ministry said that coronavirus-infected patients reporting to various COVID-19 treatment facilities have been reporting symptoms like fever, cough, fatigue, shortness of breath, expectoration, myalgia, rhinorrhea, sore throat and diarrhea.

They have also complained of loss of smell (anosmia) or loss of taste (ageusia) preceding the onset of respiratory symptoms.

Older people and immune-suppressed patients in particular may present with atypical symptoms such as fatigue, reduced alertness, reduced mobility, diarrhoea, loss of appetite, delirium, and absence of fever, the ministry said.

Children might not have reported fever or cough as frequently as adults.

The US's national public health institute, the Centers for Disease Control and Prevention (CDC), had in early May incorporated "a new loss of taste or smell" in the list of COVID-19 symptoms.

According to the data from Integrated Health Information Platform and Integrated Disease Surveillance Programme, portal case investigation forms for COVID 19 (n=15,366), the details on the signs and symptoms reported are (as on June 11), fever (27 per cent), cough (21 pc), sore throat (10 pc), breathlessness (8 pc), Weakness (7 pc), running nose (3pc ) and others 24 pc.

According to the health ministry, people infected by the novel coronavirus are the main source of infection.

Direct person-to-person transmission occurs through close contact, mainly through respiratory droplets that are released when the infected person coughs, sneezes, or talks.

These droplets may also land on surfaces, where the virus remains viable. Infection can also occur if a person touches an infected surface and then touches his or her eyes, nose, or mouth.

The median incubation period is 5.1 days (range 2–14 days). The precise interval during which an individual with COVID-19 is infectious is uncertain.

As per the current evidence, the period of infectivity starts 2 days prior to onset of symptoms and lasts up to 8 days.

The extent and role played by pre-clinical/ asymptomatic infections in transmission still remain under investigation.